Dose finding studies with imidapril—a new ACE inhibitor.

British Journal of Clinical Pharmacology

Volumn 37, Issue 3, 1994, Pages 265-272

  Vandenburg, MJ ^a   Mackay, EM ^a   Dews, I ^a   Pullan, T ^a   Brugier, S ^a  

^a MCRC ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; IMIDAZOLIDINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0028232228     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1994.tb04274.x     Document Type: Article

References (16)

1. 1989 Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH Meeting
2. Haemodynamics of hypertension
3. Haemodynamics in essential hypertension
4. Captopril
5. Haemodynamic effects of captopril in hypertensive patients. Comparison with saralasin
6. Haemodynamic effects of angiotensin‐converting enzyme inhibitors in essential hypertension: review
7. Converting enzyme inhibition with an orally active compound in hypertensive man
8. Captopril in the treatment of clinical hypertension and cardiac failure
9. A need for new converting enzyme inhibitors
10. Essential hypertension: effect of an oral inhibitor of angiotensin converting enzyme
11. Haemodynamic profile of captopril treatment in various forms of hypertension
12. Captopril: evaluation of low doses, twice daily doses and the addition of a diuretic for the treatment of mild to moderate hypertension
13. Angiotensin‐converting enzyme inhibitors: Relationship between pharmacodynamics and pharmacokinetics
14. Advances in the management of hypertension: ACE inhibitor therapy
15. Captopril and enalapril: evaluation of therapeutic efficacy and safety
16. Review of the overall experience of captopril in hypertension